Outsourcing-Pharma.com sheds some light on how pharma companies can
make sure they are choosing a contract research organisations (CRO)
that will stick to the rules of ethics when running clinical trials
in poorly-regulated countries...
eClinical software and services firm etrials has launched the
latest version of its eDiary technology, which the company claims
will lead to cost savings and increased efficiency in the clinical
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
After recent allegations in the media that poor and illiterate
patients in India are being used, often unknowingly, as human
guinea pigs to test new drugs for the pharma giants of the West,
Outsourcing-Pharma takes a look at how cutting...
Although clearing Parexel from contributing to the recent drug
trial disaster, a final UK Medicines and Healthcare products
Regulatory Agency (MHRA) report slammed the US firm for making a
number of basic errors during the trial process.
IT services company HCL Technologies continues to experience rapid
growth through its ability to undercut clinical research
organisations (CROs) on price for clinical data management (CDM)
services through its new operations in India.
US biotech company Spherix has selected Singapore-based clinical
research organisation (CRO) Gleneagles to take charge of the Phase
III clinical trial program for its new Type 2 diabetes drug,
Kendle has seized a chance to expand and diversify its business,
snapping up the Phase II-IV Clinical Services unit of Charles River
Laboratories after it decided to get out of this area of clinical
trial services and focus instead...
The market for smart pharma packaging will grow to $1.7bn (€1.3bn)
in 2013 from the current $21m, driven by the need for new clinical
trial compliance-and brand protection measures, according to a new
As PRA International's profits tumble on the back of a major
contract loss, coupled with ongoing delays in its biotech
contracts, the company has introduced new project efficiency
measures and is focusing on increasing its international...
According to a new study, efforts to increase R&D pipeline
productivity have never been more aggressive, with clinical
outsourcing being one strategy employed by big pharma to lift
itself out of the doldrums.